We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+4.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.1B
AUM Growth
–
Cap. Flow
+$20.8B
Cap. Flow
% of AUM
98.76%
Top 10 Holdings %
Top 10 Hldgs %
26.91%
Holding
1,431
New
1,431
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.1B |
| 2 |
Apple
AAPL
|
+$895M |
| 3 |
Microsoft
MSFT
|
+$781M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$593M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$523M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.88% |
| 2 | Financials | 10.47% |
| 3 | Healthcare | 9.59% |
| 4 | Consumer Discretionary | 7.62% |
| 5 | Industrials | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Smith & Nephew
SNN
$13.7B
| $330K | ﹤0.01% |
+10,056
| New | +$344K |
|
|
PRMB
1102
Primo Brands
PRMB
$8.35B
| $329K | ﹤0.01% |
+20,152
| New | +$372K |
|
1103
California Water Service
CWT
$3.1B
| $329K | ﹤0.01% |
+7,590
| New | +$346K |
|
1104
Universal Health Services
UHS
$10.2B
| $329K | ﹤0.01% |
+1,507
| New | +$333K |
|
1105
Viatris
VTRS
$20.8B
| $327K | ﹤0.01% |
+26,265
| New | +$283K |
|
1106
Exelixis
EXEL
$13.9B
| $327K | ﹤0.01% |
+7,460
| New | +$309K |
|
1107
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.12B
| $327K | ﹤0.01% |
+1,417
| New | +$325K |
|
1108
Buckle
BKE
$2.32B
| $325K | ﹤0.01% |
+6,076
| New | +$339K |
|
1109
PennyMac Financial
PFSI
$4.47B
| $324K | ﹤0.01% |
+2,458
| New | +$313K |
|
1110
Avient
AVNT
$3.29B
| $322K | ﹤0.01% |
+10,316
| New | +$319K |
|
1111
Hormel Foods
HRL
$14.2B
| $322K | ﹤0.01% |
+13,575
| New | +$317K |
|
1112
Timken Company
TKR
$9.19B
| $320K | ﹤0.01% |
+3,808
| New | +$303K |
|
1113
Provident Financial Services
PFS
$3.14B
| $320K | ﹤0.01% |
+16,196
| New | +$313K |
|
1114
Castle Biosciences
CSTL
$742M
| $319K | ﹤0.01% |
+8,190
| New | +$264K |
|
1115
Infosys
INFY
$51B
| $319K | ﹤0.01% |
+17,876
| New | +$309K |
|
1116
Allison Transmission
ALSN
$9.51B
| $317K | ﹤0.01% |
+3,243
| New | +$284K |
|
1117
Insmed
INSM
$22.4B
| $316K | ﹤0.01% |
+1,818
| New | +$332K |
|
1118
Core Scientific
CORZ
$5.79B
| $316K | ﹤0.01% |
+21,697
| New | +$378K |
|
1119
Saia
SAIA
$10.5B
| $316K | ﹤0.01% |
+967
| New | +$292K |
|
1120
Packaging Corp of America
PKG
$22.2B
| $316K | ﹤0.01% |
+1,530
| New | +$311K |
|
1121
Acuity Brands
AYI
$9.99B
| $315K | ﹤0.01% |
+874
| New | +$316K |
|
1122
Carlyle Secured Lending
CGBD
$708M
| $314K | ﹤0.01% |
+25,175
| New | +$313K |
|
|
VPU
1123
Vanguard Utilities ETF
VPU
$8.56B
| $314K | ﹤0.01% |
+1,698
| New | +$326K |
|
1124
East-West Bancorp
EWBC
$17.8B
| $314K | ﹤0.01% |
+2,794
| New | +$297K |
|
1125
Nuveen Select Tax-Free Income Portfolio
NXP
$898M
| $313K | ﹤0.01% |
+22,195
| New | +$319K |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Glenmede Trust, which disclosed 1,431 positions worth $21.1B. Its ten largest holdings account for 27% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 1,772,161 shares worth $1.11B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Healthcare.
- Glenmede Trust's largest Q4 2025 buy was Vanguard S&P 500 ETF: 1,772,161 shares worth $1.11B.
- Glenmede Trust's ten largest holdings make up 27% of its $21.1B portfolio in Q4 2025.
- Glenmede Trust disclosed 1,431 positions in Q4 2025, its first 13F filing on record.
Based on Glenmede Trust's 13F filing for Q4 2025, filed 17 Feb 2026.